This article describes the use of bacteriophages in surgery, where antibiotics often fail. It explains the mechanisms of phage action, their advantages, examples of clinical use, and future developments.
Phage therapy is rapidly developing and is already being used in medicine in Georgia, Poland, France, and Ukraine. These countries are demonstrating that bacteriophages can effectively treat resistant infections and offer a safe alternative to antibiotics. Ukraine has all the potential to become a leader in this field.
Phages are becoming a safe alternative to antibiotics in pediatric medicine: these sniper viruses destroy only dangerous bacteria without disrupting the normal microflora. This article explains how bacteriophages work, what diseases they treat in children, and why parents and doctors are increasingly turning to phage therapy.
An invisible war against resistant infections is raging within hospitals. Phage therapy, a forgotten treatment and prevention method, is making a comeback as an alternative to antibiotics. This article examines the benefits of phages, examples of their use in hospitals, and the need for a personalized approach.
Antibiotics have lost their absolute effectiveness, and bacterial resistance has become a devastating pandemic. This article describes why bacteriophages could be a lifesaver in this time of global crisis, where they are already being used, and the challenges facing their widespread adoption.
Invisible helpers of humanity — bacteriophages — are joining the fight against superbugs. The article describes their unique powers, the importance of action aimed at preserving the microbiome, the application of stagnation in medicine and the rural state, as well as new horizons of phage therapy, including phage banks and genetic modification of phages.
Bacteriophages and bacteria have been engaged in an evolutionary race for billions of years. This article addresses the question of whether bacteria can become insensitive to phages, describes the mechanisms of resistance, and emphasizes that loss of sensitivity is often accompanied by a weakening of the bacteria. It also presents strategies for preventing the development of resistance.
Antibiotic resistance is returning the pharmaceutical industry's attention to bacteriophages. This article discusses the reasons why pharmaceutical giants are investing in phage therapy, lists pioneering companies, describes regulatory shifts in the EU and US, and highlights the prospects for a personalized approach, including phage cocktails.
Bacteriophages have long been studied in laboratories, but only now are research results beginning to be widely applied in the clinic. This article explores the emerging fields, the drugs already undergoing trials, and why phage therapy is poised to become a part of modern medicine.
Phage therapy opens a new chapter in the treatment of acne and skin infections. Bacteriophages can target harmful bacteria without disrupting the skin's microflora and may become a safe alternative to antibiotics. Scientific studies are already confirming the effectiveness of this approach, promising a revolution in dermatology.
